We are using cookies This website uses cookies in order to offer you the most relevant information. By browsing this website, you accept these cookies.
Some SMBG time points had a stronger association with A1C than others.
2
Higher levels of A1c suggest worse blood sugar control and possibly diabetes.
3
Blood pressure and hemoglobin A1c did not differ among the four groups.
4
They were more likely to document patient height, urinalyses results, and A1C values.
5
High A1C levels mean a high risk of complications from diabetes.
1
Primary outcome: We evaluated mean change in blood glycatedhemoglobin levels.
2
Glycemic control was based on glycatedhemoglobin levels and fasting blood glucose test.
3
Measurements and main results: We used admission glycatedhemoglobin to estimate premorbid baseline blood glucose concentration.
4
Higher total cholesterol, glycatedhemoglobin and insulin resistance parameters are connected with lower central dopamine tone.
5
Glucose-lowering therapies were granted regulatory approval primarily from smaller studies that have demonstrated reductions in glycatedhemoglobin concentration.
1
Baseline BMI predicted greater fasting glucose and HgbA1c levels at 12 months for both treatments.
Usage of hba1c in English
1
The bootstrapping method was used to estimate average BG and corresponding HbA1c.
2
Subgroup analyses were done in diabetic patients according to their Hba1C levels.
3
HbA1c determinations were centralized in a Diabetes Control and Complications Trial-controlled laboratory.
4
The HbA1c is a really important test that we use all the time.
5
Conclusions: This study showed that HbA1c is a good predictor of in-hospital morbidity.
6
There was no significant correlation between the ox-LDL level and the HbA1c level.
7
Averaged annual HbA1c levels over time were not associated with outcomes.
8
Glycemic control in the diabetic cohort was assessed using preoperative HbA1c.
9
Fasting plasma glucose concentration and HbA1c were measured for each individual.
10
Routine automated HbA1c testing was performed in all hematology and oncology in …
11
There were significant reductions in HbA1c, total cholesterol and liver stiffness.
12
Look beyond the HbA1c average, and consider introducing insulin earlier in the disease process.
13
However, changes in HbA1c were not correlated with any changes in the CGMS variables.
14
In the multiple regression analysis, HbA1c level remained significantly associated with these histologic parameters.
15
We determine relationship of HbA1c with severity and outcome in patients with stable CAD.
16
Usual HbA1c measurement was calculated using a mixed-effects model to minimize regression dilution bias.